-transparent.png){kind=logo}
39 patients with testicular germ cell tumor metastases were treated with vinblastine intravenous bolus injection day 1 and day 36 and bleomycin intramuscularly twice weekly for 10 weeks. 8 patients had complete remission. 4 of these are alive with no evidence of disease for 91 + to 109 + months. Studied with Wilk's method for stepwise discriminant analysis tumor volume and performance status significantly predicted the patients who had complete remission. Studied with Cox's proportional hazard model for multivariate analysis hCG in the primary tumor, serum lactate dehydrogenase, performance status, and complete remission had a significant impact on survival. The information from the risk factors may be useful in a differentiated treatment of patients with testicular germ cell tumor metastases.
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
October 1989,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
January 1985,
Progress in clinical and biological research,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
August 2002,
Cancer,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
June 2003,
The Journal of urology,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
August 1990,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
January 1982,
Obstetrics and gynecology,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
January 1979,
Medical and pediatric oncology,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
September 1985,
Cancer,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
November 2023,
Cureus,
F E von Eyben, and
G K Jacobsen, and
H Pedersen, and
M Jacobsen, and
P P Clausen, and
P C Zibrandtsen, and
B Gullberg
March 2016,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
